ASX - Delayed Quote AUD

Argent BioPharma Limited (RGT.AX)

0.1400

-0.0200

(-12.50%)

At close: 3:14:18 PM GMT+11

Argent BioPharma Ltd. Raised US$4,500,000

Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.

PR Newswire 23 days ago

RGTLF

RQHTF
Argent BioPharma Ltd. Placing to Raise US$4,500,000

Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.

PR Newswire 24 days ago

RGTLF
Insider Spends AU$1.6m Buying More Shares In Argent BioPharma

Those following along with Argent BioPharma Limited ( ASX:RGT ) will no doubt be intrigued by the recent purchase of...

Simply Wall St. 3 months ago

RGTLF
Co-Founder of Argent BioPharma Picks Up 3,721% More Stock

Investors who take an interest in Argent BioPharma Limited ( ASX:RGT ) should definitely note that the Co-Founder, Roby...

Simply Wall St. 4 months ago

RGTLF
Argent BioPharma Full Year 2024 Earnings: AU$0.47 loss per share (vs AU$7.07 loss in FY 2023)

Argent BioPharma ( ASX:RGT ) Full Year 2024 Results Key Financial Results Revenue: AU$891.1k (down 74% from FY 2023...

Simply Wall St. 4 months ago

RGTLF

Performance Overview

Return	RGT.AX	S&P/ASX 200 [XJO]
YTD	-17.65%	+4.57%
1-Year	-67.82%	+11.09%
3-Year	-67.82%	+22.39%